Evidence map›Paper›PMID 38600235›Full record

ArticleNature cell biology2024

Transcription-coupled repair of DNA-protein cross-links depends on CSA and CSB.

Christopher J Carnie, Aleida C Acampora, Aldo S Bader, Chimeg Erdenebat, Shubo Zhao, Elnatan Bitensky, Diana van den Heuvel, Avital Parnas, Vipul Gupta, Giuseppina D'Alessandro and 15 more

Abstract read
In one paragraph

Article in Nature cell biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Christopher J Carnie *Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. chris.carnie@cruk.cam.ac.uk.ORCID 0000-0001-7006-5596
Aleida C Acampora *Gene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Aldo S BaderCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5760-5113
Chimeg ErdenebatGene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Shubo ZhaoGene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Elnatan BitenskyDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Diana van den HeuvelDepartment of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Avital ParnasDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Vipul GuptaThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Giuseppina D'AlessandroCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5448-8652
Matylda Sczaniecka-CliftThe Gurdon Institute and Department of Biochemistry, University of Cambridge, Cambridge, UK.
Pedro WeickertGene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Fatih AygenliInstitute of Medical Psychology and Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Maximilian J GötzGene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Jacqueline CordesGene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany.
Isabel Esain-GarciaCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Larry MelidisCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0001-6853-2722
Annelotte P WondergemDepartment of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Simon LamCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4476-0971
Maria S RoblesInstitute of Medical Psychology and Biomedical Center, Faculty of Medicine, Ludwig-Maximilians-Universität München, Munich, Germany.
Shankar BalasubramanianCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
Sheera AdarDepartment of Microbiology and Molecular Genetics, The Institute for Medical Research Israel-Canada, The Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
Martijn S LuijsterburgDepartment of Human Genetics, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-5796-6541
Stephen P JacksonCancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK. steve.jackson@cruk.cam.ac.uk.ORCID 0000-0001-9317-7937
Julian StingeleGene Center and Department of Biochemistry, Ludwig-Maximilians-Universität München, Munich, Germany. stingele@genzentrum.lmu.de.ORCID 0000-0001-6020-2075

Funding

Alfried Krupp von Bohlen und Halbach-Stiftung (Alfried Krupp von Bohlen und Halbach Foundation) Alfried Krupp Prize for Young University TeachersCancer Research UK 19836Cancer Research UK (CRUK) A:29580Cancer Research UK (CRUK) C9545/A19836Cancer Research UK (CRUK) C9681/A29214Cancer Research UK (CRUK) CRUK Discovery Award DRCPGM\100005Cancer Research UK (CRUK) CRUK RadNet grant C17918/A28870Cancer Research UK (CRUK) Discovery Award DRCPGM\100005Deutsche Forschungsgemeinschaft (German Research Foundation) Project-ID 393547839 - SFB 1361Deutsche Forschungsgemeinschaft (German Research Foundation) SFB824EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 101043815EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 801750EC | EU Framework Programme for Research and Innovation H2020 | H2020 Priority Excellent Science | H2020 European Research Council (H2020 Excellent Science - European Research Council) 855741European Molecular Biology Laboratory (EMBL Heidelberg) YIP4644Israel Cancer Research Fund (Israel Cancer Research Fund, Inc.) 20-203-RCDAIsrael Science Foundation (ISF) 482/22Vallee Foundation (Bert L. & N. Kuggie Vallee Foundation) Vallee Scholar AwardWellcome Trust
6 · The paper itself

Abstract

Covalent DNA-protein cross-links (DPCs) are toxic DNA lesions that block replication and require repair by multiple pathways. Whether transcription blockage contributes to the toxicity of DPCs and how cells respond when RNA polymerases stall at DPCs is unknown. Here we find that DPC formation arrests transcription and induces ubiquitylation and degradation of RNA polymerase II. Using genetic screens and a method for the genome-wide mapping of DNA-protein adducts, DPC sequencing, we discover that Cockayne syndrome (CS) proteins CSB and CSA provide resistance to DPC-inducing agents by promoting DPC repair in actively transcribed genes. Consequently, CSB- or CSA-deficient cells fail to efficiently restart transcription after induction of DPCs. In contrast, nucleotide excision repair factors that act downstream of CSB and CSA at ultraviolet light-induced DNA lesions are dispensable. Our study describes a transcription-coupled DPC repair pathway and suggests that defects in this pathway may contribute to the unique neurological features of CS.

Indexed as

Cockayne SyndromeDNA HelicasesDNA RepairDNA Repair EnzymesPoly-ADP-Ribose Binding ProteinsRNA Polymerase IIDNA AdductsDNA DamageExcision RepairHumansReceptors, Interleukin-17Transcription FactorsTranscription, GeneticUbiquitinationUltraviolet RaysDNA AdductsDNA HelicasesDNA Repair EnzymesERCC6 protein, humanERCC8 protein, humanIL17RB protein, humanPoly-ADP-Ribose Binding ProteinsReceptors, Interleukin-17RNA Polymerase IITranscription Factors

Identifiers

PMID38600235
PMCPMC11098753

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.